drug
deutetrabenazine
Marketedupdated 5mo agoby Teva Pharmaceuticals USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying deutetrabenazine
- phase3Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
- phase4Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Patients With Huntington's Disease (HD) Chorea in China
- phase4Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
- phase2An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia
News(2)
- Federal appeals court revives part of Teva's IRA case as Austedo price cuts loomAfter a lower court rejected Teva's case last fall, a federal appeals court has revived part of the drugmaker’s lawsuit against Medicare negotiations. The DC Circuit Court ruled on Tuesday that Tev…endpoints · 1mo ago
- Teva nabs experimental Tourette drug in $700M Emalex buyoutA Jefferies analyst argued the deal — Teva’s largest in a decade — “makes sense” given the synergies between Emalex and the pharmaceutical giant’s neurology business.biopharma_dive · 5mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that